Chemical Structure (Daptomycin 01)
Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 70594-053
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 70594-053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Xellia Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (350 mg Vial Carton)
This is a description of Daptomycin for Injection, a medication used for intravenous infusion. Each single-dose vial contains 350mg of the medication, which should be reconstituted with 0.9% Sodium Chloride Injection to obtain a final concentration of 50mg/mL. The medication should be refrigerated between 2°C - 8°C and discarded if unused. The package insert contains instructions for reconstitution, dosage, and administration. The manufacturer is Xellia Pharmaceuticals USA, LLC. Parenteral drug products should be visually inspected for particulate matter before administration.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
